749929-28-0 Usage
Description
(6-chloro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methanol is a chemical compound belonging to the triazolopyrimidine family, characterized by the molecular formula C6H5ClN4O. (6-chloro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methanol features a chloro group and a methanol functional group, which contribute to its potential applications in various fields.
Uses
Used in Pharmaceutical Industry:
(6-chloro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methanol is used as a building block for the synthesis of biologically active compounds. Its unique structure and functional groups make it a promising candidate for the development of new drugs, targeting a range of medical conditions.
Used in Agrochemical Industry:
In the agrochemical industry, (6-chloro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methanol is used as a precursor for the development of new agrochemicals. Its potential biological activities can be harnessed to create innovative products for crop protection and enhancement of agricultural yields.
Further research and development studies are necessary to fully explore the potential uses and properties of (6-chloro-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methanol, as its applications in both the pharmaceutical and agrochemical industries are still being investigated.
Check Digit Verification of cas no
The CAS Registry Mumber 749929-28-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,9,9,2 and 9 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 749929-28:
(8*7)+(7*4)+(6*9)+(5*9)+(4*2)+(3*9)+(2*2)+(1*8)=230
230 % 10 = 0
So 749929-28-0 is a valid CAS Registry Number.
749929-28-0Relevant articles and documents
INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME
-
Page 140, (2008/06/13)
The invention relates to compounds of the formula (I) and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula (I), and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula (I). The invention also relates to methods of preparing the compounds of formula (I).
